Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves' Disease

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 1988 Jan 1

PMID 2908684

Citations 1

Authors

W Y Cho

H H Choi

H J Chun

I M Ahn

Affiliations

Soon will be listed here.

Citing Articles

Thyrotoxic Periodic Paralysis With Hypokalemia: A Case Study.

Mebane N, Khan A, Bevinal M, Davis E Cureus. 2023; 15(6):e40757.

PMID: 37485151 PMC: 10361783. DOI: 10.7759/cureus.40757.

References

Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y . Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1978; 46(5):734-9. DOI: 10.1210/jcem-46-5-734. View

McLachlan S, Pegg C, Atherton M, MIDDLETON S, Clark F, Rees Smith B . TSH receptor antibody synthesis by thyroid lymphocytes. Clin Endocrinol (Oxf). 1986; 24(2):223-30. DOI: 10.1111/j.1365-2265.1986.tb00766.x. View

Drexhage H, Bottazzo G, Bitensky L, Chayen J, Doniach D . Thyroid growth-blocking antibodies in primary myxoedema. Nature. 1981; 289(5798):594-6. DOI: 10.1038/289594a0. View

Smith B, Hall R . Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974; 2(7878):427-31. DOI: 10.1016/s0140-6736(74)91815-7. View

Valente W, Vitti P, Rotella C, Vaughan M, Aloj S, Grollman E . Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. N Engl J Med. 1983; 309(17):1028-34. DOI: 10.1056/NEJM198310273091705. View

Benveniste P, Row V, Volpe R . Studies on the immunoregulation of thyroid autoantibody production in vitro. Clin Exp Immunol. 1985; 61(2):274-82. PMC: 1577288. View

Endo K, AMIR S, Ingbar S . Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease. J Clin Endocrinol Metab. 1981; 52(6):1113-23. DOI: 10.1210/jcem-52-6-1113. View

Onaya T, Kotani M, Yamada T, Ochi Y . New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. J Clin Endocrinol Metab. 1973; 36(5):859-66. DOI: 10.1210/jcem-36-5-859. View

Zakarija M, McKenzie J . Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP. Metabolism. 1973; 22(9):1185-91. DOI: 10.1016/0026-0495(73)90206-0. View

10.

Raines K, Baker Jr J, Lukes Y, Wartofsky L, Burman K . Antithyrotropin antibodies in the sera of Graves' disease patients. J Clin Endocrinol Metab. 1985; 61(2):217-22. DOI: 10.1210/jcem-61-2-217. View

11.

Docter R, Bos G, Visser T, Hennemann G . Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clin Endocrinol (Oxf). 1980; 12(2):143-53. DOI: 10.1111/j.1365-2265.1980.tb02129.x. View

12.

Mukhtar E, Smith B, Pyle G, Hall R, Vice P . Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet. 1975; 1(7909):713-5. DOI: 10.1016/s0140-6736(75)91629-3. View

13.

Iida Y, Konishi J, Kousaka T, Misaki T, Nakajima T, Endo K . [Clinical usefulness of the assay of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease: Effect of antithyroid drug treatment on TBII and prognosis]. Kaku Igaku. 1983; 20(10):1425-31. View

14.

Bottazzo G, Pujol-Borrell R, Hanafusa T, Feldmann M . Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 1983; 2(8359):1115-9. DOI: 10.1016/s0140-6736(83)90629-3. View

15.

Manley S, BOURKE J, Hawker R . The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator. J Endocrinol. 1974; 61(3):437-45. DOI: 10.1677/joe.0.0610437. View